STUDIO 111 CLINICAL SERVICES LIMITED

Company Registration Number:
03930458 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 29 February 2024

End date: 31 March 2025

STUDIO 111 CLINICAL SERVICES LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

STUDIO 111 CLINICAL SERVICES LIMITED

Balance sheet

As at 31 March 2025


Notes
13 months to 31 March 2025
2024


£
£
Fixed assets
Tangible assets: 3 1,590 2,739
Total fixed assets: 1,590 2,739
Current assets
Debtors:   79,077 241,752
Cash at bank and in hand: 203,353 145,940
Total current assets: 282,430 387,692
Creditors: amounts falling due within one year:   (46,077) (139,685)
Net current assets (liabilities): 236,353 248,007
Total assets less current liabilities: 237,943 250,746
Creditors: amounts falling due after more than one year:   (142,347) (217,169)
Total net assets (liabilities): 95,596 33,577
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 95,496 33,477
Shareholders funds: 95,596 33,577

The notes form part of these financial statements

STUDIO 111 CLINICAL SERVICES LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 19 December 2025
and signed on behalf of the board by:

Name: A MCDONNELL
Status: Director

The notes form part of these financial statements

STUDIO 111 CLINICAL SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

STUDIO 111 CLINICAL SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

13 months to 31 March 2025 2024
Average number of employees during the period 14 14

STUDIO 111 CLINICAL SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 29 February 2024 41,667
At 31 March 2025 41,667
Depreciation
At 29 February 2024 38,928
Charge for year 1,149
At 31 March 2025 40,077
Net book value
At 31 March 2025 1,590
At 28 February 2024 2,739